# Inhibikase Therapeutics Inc. (IKT) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2024 | — |
| 2023 | $260,501 |
| 2022 | $123,440 |
| 2021 | $3M |
| 2020 | $698,468 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | — |
| 2025-09-30 | — |
| 2025-06-30 | — |
| 2025-03-31 | — |
| 2024-09-30 | — |
| 2024-06-30 | — |
| 2024-03-31 | — |
| 2023-09-30 | $79,569 |
| 2023-06-30 | $116,410 |
| 2023-03-31 | $64,521 |
| 2022-09-30 | $7,291 |
| 2022-06-30 | $6,552 |
| 2022-03-31 | $46,031 |
| 2021-09-30 | $328,459 |
| 2021-06-30 | $1M |
| 2021-03-31 | $1M |
| 2020-09-30 | $37,680 |
| 2020-06-30 | $219,585 |
| 2020-03-31 | $270,787 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/IKT/revenue)